Peptides for libido: treating the vascular, hormonal and metabolic causes honestly.

Libido is a symptom, not a diagnosis

Desire is downstream of several systems at once: sex hormones, vascular function, sleep quality, metabolic health, mood, medication and relationship context. When it drops, one or more of those has changed — and the useful question is which, because the treatments are not interchangeable.

In men, the common drivers are genuinely low testosterone, vascular disease, poor sleep or untreated apnea, visceral fat driving hormonal conversion, antidepressants, alcohol, and stress. Erectile dysfunction deserves special emphasis: it is often the earliest visible sign of vascular disease, and it can precede a cardiac event by years. That makes it a reason to get a cardiovascular workup, not just a prescription.

In women, the picture usually involves the perimenopausal hormone shift, vaginal dryness and pain that make sex something to avoid, exhaustion, medication effects — particularly SSRIs — and the well-documented reality that desire often follows arousal rather than preceding it. Treating pain and dryness with local estrogen frequently does more for libido than anything else on the list.

Where peptides fit — and where they do not

Sermorelin supports your own nocturnal growth-hormone pulses, which improves sleep depth, body composition and energy. That matters because libido tracks vitality closely: people who are exhausted, carrying excess visceral fat and sleeping shallowly rarely have strong desire regardless of hormone levels. Sermorelin does not raise testosterone or estrogen.

NAD+ supports mitochondrial energy production, and MOTS-c is studied for metabolic and mitochondrial function with particular relevance to visceral fat and insulin sensitivity. Reducing visceral fat improves the hormonal environment in men, since abdominal fat increases the conversion of testosterone to estrogen. Glutathione lowers oxidative burden, which is part of endothelial — blood vessel — health.

Here is the honest limit: none of these is a direct libido drug. PT-141 is the peptide with actual central-nervous-system desire data, and PDE5 inhibitors are the evidence-based treatment for erectile function; testosterone replacement is the treatment for genuinely low testosterone, and local estrogen is the treatment for vaginal atrophy. Your consult will point you at those when they are what you need, including through our Origin Peak pathway for men.

Researched benefits

No peptide on this page is FDA-approved for low libido or sexual dysfunction. Sermorelin's use is off-label. MOTS-c human evidence is early. NAD+ and glutathione have biochemical rationale rather than sexual-function trial data. The treatments with real evidence in this space are different ones: PDE5 inhibitors for erectile dysfunction, testosterone replacement for confirmed hypogonadism, local estrogen for genitourinary symptoms of menopause, and PT-141 for hypoactive sexual desire. We would rather route you to the right treatment than sell you an adjacent one.

How sexual health protocol is dosed

Workup first, and it is not optional here. For men: morning total and free testosterone on two separate days, LH, prolactin, estradiol, HbA1c, a lipid panel, thyroid and a blood pressure check. Erectile dysfunction, especially before fifty, gets a genuine cardiovascular risk assessment. For women: thyroid, ferritin, and a discussion of cycle status, vaginal symptoms, pain with sex, and current medications.

Medication review matters more than most people expect. SSRIs, finasteride, beta blockers, opioids and hormonal contraceptives all affect desire and function, and sometimes the answer is a conversation with the prescribing clinician rather than a new prescription.

Where a peptide protocol is right, sermorelin usually anchors it, dosed at night. MOTS-c is added where visceral fat and metabolic health are central, NAD+ for energy, glutathione for oxidative load.

Timelines: sleep and energy in three to six weeks; body composition and hormonal environment in two to four months. If confirmed low testosterone is the driver, replacement works faster and better, and we will tell you that instead of stretching a peptide protocol out.

• Injectable (subcutaneous)

  Subcutaneous injection. Sermorelin nightly; MOTS-c, NAD+ and glutathione on a schedule set by your prescriber. All protocols include supplies, guidance and clinician oversight.

At Origin Wellness, dosing is never self-directed. Your protocol is written by a licensed physician after reviewing your assessment, and it is adjusted at follow-up based on your response. Read more about how that review works on our approach page.

Safety, side effects, and who should avoid it

Sexual symptoms are unusually informative medically. Erectile dysfunction can be the first sign of coronary disease or diabetes; loss of libido with headaches or visual changes can indicate a pituitary problem; pain with sex in women has a real differential that includes endometriosis and infection. None of that should be smoothed over with a wellness protocol.

• • New erectile dysfunction warrants cardiovascular and metabolic evaluation — it is often the earliest warning sign of vascular disease.
• • Confirmed low morning testosterone points to replacement therapy, not a peptide; we discuss that through our Origin Peak pathway.
• • Low libido with headaches, visual changes or nipple discharge needs prolactin testing and imaging.
• • Pain with intercourse needs gynecologic evaluation; it is a medical problem, not a motivation problem.
• • Sermorelin requires review of cancer history before prescribing, and is not appropriate with active malignancy.
• • Not for use during pregnancy or breastfeeding.
• • Alcohol, opioids, SSRIs, finasteride and beta blockers all affect sexual function — review medications before adding anything.
• • Untreated sleep apnea lowers testosterone and libido; a peptide will not correct it.

How sexual health protocol fits into a full protocol

This fits men whose testosterone is normal but whose energy, sleep and body composition have declined, and who want to preserve fertility rather than start replacement. It fits women whose desire has faded alongside exhaustion and midsection weight gain, particularly through the perimenopausal window, and often alongside hormone therapy.

It is not a fit for someone with confirmed low testosterone, untreated apnea, unevaluated erectile dysfunction, or untreated pain with sex. All four have better answers, and we will name them.

Start a sexual health protocol

Every protocol is prescribed after review by a licensed clinician and includes medication, supplies and ongoing oversight.

Frequently asked questions